The Cooper Companies, Inc. (COO)

Market Cap	18.02B
Revenue (ttm)	3.67B
Net Income (ttm)	290.80M
Shares Out	198.76M
EPS (ttm)	1.46
PE Ratio	61.84
Forward PE	25.81
Dividend	$0.01 (0.01%)
Ex-Dividend Date	Jul 26, 2023

Volume	690,228
Open	90.92
Previous Close	90.41
Day's Range	90.32 - 90.99
52-Week Range	75.94 - 104.07
Beta	0.95
Analysts	Buy
Price Target	109.48 (+20.75%)
Earnings Date	May 30, 2024

About COO

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health car...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1980
• Employees: 15,000
• Stock Exchange: NASDAQ
• Ticker Symbol: COO

Financial Performance

In 2023, COO's revenue was $3.59 billion, an increase of 8.61% compared to the previous year's $3.31 billion. Earnings were $294.20 million, a decrease of -23.74%.

Analyst Forecast

According to 12 analysts, the average rating for COO stock is "Buy." The 12-month stock price forecast is $109.48, which is an increase of 20.75% from the latest price.

Price Target

$109.48

(20.75% upside)

Analyst Consensus: Buy